Epigenetic regulators of the revascularization response to chronic arterial occlusion
- 15 March 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 115 (4) , 701-712
Abstract
Peripheral arterial disease (PAD) is the leading cause of lower limb amputation and estimated to affect over 202 million people worldwide. PAD is caused by atherosclerotic lesions that occlude large arteries in the lower limbs, leading to insufficient blood perfusion of distal tissues. Given the severity of this clinical problem, there has been long-standing interest in both understanding how chronic arterial occlusions affect muscle tissue and vasculature and identifying therapeutic approaches capable of restoring tissue composition and vascular function to a healthy state. To date, the most widely utilized animal model for performing such studies has been the ischaemic mouse hindlimb. Despite not being a model of PAD per se, the ischaemic hindlimb model does recapitulate several key aspects of PAD. Further, it has served as a valuable platform upon which we have built much of our understanding of how chronic arterial occlusions affect muscle tissue composition, muscle regeneration and angiogenesis, and collateral arteriogenesis. Recently, there has been a global surge in research aimed at understanding how gene expression is regulated by epigenetic factors (i.e. non-coding RNAs, histone post-translational modifications, and DNA methylation). Thus, perhaps not unexpectedly, many recent studies have identified essential roles for epigenetic factors in regulating key responses to chronic arterial occlusion(s). In this review, we summarize the mechanisms of action of these epigenetic regulators and highlight several recent studies investigating the role of said regulators in the context of hindlimb ischaemia. In addition, we focus on how these recent advances in our understanding of the role of epigenetics in regulating responses to chronic arterial occlusion(s) can inform future therapeutic applications to promote revascularization and perfusion recovery in the setting of PAD.Keywords
Funding Information
- National Institutes of Health Grants (R01EB020147, R21EB024323)
- Cardiovascular Research Center (T32HLI007284)
- National Institutes of Health
- American Heart Association fellowship (18PRE34030022)
This publication has 175 references indexed in Scilit:
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Tobacco-Smoking-Related Differential DNA Methylation: 27K Discovery and ReplicationThe American Journal of Human Genetics, 2011
- Epigenetics and cardiovascular diseaseNature Reviews Cardiology, 2010
- Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesisJournal of Vascular Surgery, 2009
- Collateral circulationBasic Research in Cardiology, 2009
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and AngiogenesisDevelopmental Cell, 2008
- The chemokine system in arteriogenesis and hind limb ischemiaJournal of Vascular Surgery, 2007
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Prediction of Mammalian MicroRNA TargetsCell, 2003